Wearables for everyone? I dug into the evidence behind the health tools RFK wants all Americans to use. endpoints.news/the-trump-ad...

Scoop! Calibrate has replaced its CEO and made several other executive changes, the latest leadership reset at the once high-flying weight loss company. endpts.com/weight-loss-...

NEW: Empower Pharmacy, which calls itself the US’ “largest and most advanced” compounding pharmacy, has used poor-quality ingredients, skirted regulations and pushed out or sued employees who raised concerns, an Endpoints News investigation found. endpts.com/pharmacy-emp...

$13 billion startup Devoted Health grew revenue to $3.3 billion in 2024 and shrank its operating losses, according to my analysis of state insurance filings. endpts.com/devoted-heal...

10,000 job cuts hitting HHS as part of a gigantic agency reorg. @zacharybrennan.bsky.social has the breaking news: endpts.com/hhs-plans-to...

Akido Labs is letting AI take the reins at the clinic, all the way from intake to diagnosis. "Our objective here is to pull the physician out of the room for as much time as we can, so that the physician can run many more visits in parallel," the CTO said. endpts.com/how-akido-la...

I caught up with GoodRx's new CEO Wendy Barnes. “This platform should be valued considerably higher, given what we delivered historically and the plan that we’ve laid out for ‘25 and beyond. But we’ve got a job to do to school investors to help them to understand that.” endpts.com/goodrx-ceo-w...

We won!

No semaglutide shortage, no problem. Hims execs said Monday evening that its weight loss biz is projected to drive at least $725 million in revenue for the company this year — almost a third of the revenue Hims expects to pull in across the entire company. endpts.com/hims-eyes-gr...

There's no quick fix to the problems plaguing CVS' health insurance biz. endpts.com/what-cvs-is-...

Competition from compounded GLP-1s is cutting into demand for Novo Nordisk’s prescriptions. "Our latest market intelligence does tell us and show us that it is having an impact and it is growing faster than we had anticipated,” a Novo exec said Wednesday. endpts.com/novo-nordisk...

Novo Nordisk’s blockbuster GLP-1 products Ozempic and Wegovy are among the next 15 drugs subject to the government’s Medicare negotiation program under the Inflation Reduction Act. See the rest of the list here: endpts.com/novo-nordisk...

Since the killing of UnitedHealth's top insurance exec and the subsequent outpouring of public frustration with delayed and denied care, a major question has circled the giant: Will it change how it does business? So far, there’s little sign big reforms are in the works. endpts.com/unitedhealth...

I got the rundown from Swati Mathai, longtime Elevance Health exec, about her new health plan startup XO Health. endpts.com/xo-health-la...

Tirzepatide shortage is over, says FDA. That means compounding pharmacies making lots of copies of brand-name Zepbound and Mounjaro have to stop soon. endpts.com/in-blow-to-c...

New: While “prescribing” food is far from the norm, the next administration could change that. Some startups in the food-as-medicine space are already fielding calls from interested investors. From me and @lydiapflanzer.bsky.social endpts.com/food-as-medi...

FDA’s No. 2, who was training as Califf’s replacement, said today she will leave the agency at the end of 2024 t.co/CrGcjj83Qu

NEW: A look inside Isomorphic Labs, the startup trying to change how drugs are discovered with AI. I spent time with Iso CEO (and recent Nobel laureate) Demis Hassabis and other leaders in their London headquarters. Here's my exclusive feature on what they're up to: endpts.com/isomorphic-l...

A good one from @tradeoffs.bsky.social @dgorenstein.bsky.social tradeoffs.org/2024/12/12/h...

When you keep your enemies close... Eli Lilly and Ro have formed an unlikely partnership, with Ro now offering cash-pay Zebpound vials through its app. Recall that Ro has offered compounded GLP-1 drugs, which Lilly and Novo have railed against. endpts.com/eli-lilly-ha...

My latest: The killing of UnitedHealthcare's CEO has highlighted the threats increasingly faced by healthcare execs and prompted companies to rethink how they keep their top brass safe. “This is a huge wake-up call,” the head of exec protection at Allied Universal said. endpts.com/health-execs...